Many insurance providers recognize the need for weight loss treatments, and coverage for oral semaglutide is common when it's deemed medically necessary
Recent funding from the Congressionally Directed Medical Research Program will support a multi-site study that should kick off by the end of the year, and Schacht suspects approval of a GLP-1 drug for AUD in less than three years
All statistical analyses were performed using STATA statistical software, version 17 (StataCorp, College Station, TX, USA)
The incidence of markedly low serum potassium (less than 3 mEq/L, and a reduction from pre-treatment of greater than 0.5 mEq/L) at any time during the trial was 0.2% for QSYMIA 7.5 mg/46 mg dose and 0.7% for QSYMIA 15 mg/92 mg dose, compared to 0.0% for placebo
Gut microbiota and acylcarnitine metabolites connect the beneficial association between equol and adiposity in adults: a prospective cohort study